Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results

Record second quarter 2024 revenue of $6.6 million, representing growth of 32% compared to the second quarter of 2023 150th Growth Direct® system placed with an existing top 15 global pharma customer First Growth Direct Rapid Sterility system placed with an existing top 10 global pharma customer Gross margin improved by 35 percentage points compared to the second quarter of 2023, and by 24 percentage points compared to the first quarter of 2024 Announces operational efficiency program that is expected to en ...